Evaluation of volumetric and morphological changes of vestibular schwannomas following CyberKnife therapy

Year 2019, Volume: 29 Issue: 2, 61 - 66, 03.06.2019

Engin Uğur Yardımcı Melda Apaydın Fazıl Gelal Fatih Dağ Ali Özmezoğlu Ali Fırat Sarp

Abstract

Objectives: This study aims to evaluate volumetric and morphological changes following CyberKnife radiotherapy of vestibular schwannomas. Patients and Methods: Between March 2011 and December 2013, a total of 39 patients 15 males, 24 females; mean age 52 years; range, 19 to 86 years who underwent CyberKnife hypofractionated radiotherapy were retrospectively analyzed. Tumor volume calculations were done by manual segmentation. Tumor morphology was classified by arbitrary cystic scaling. Local tumor control, tumor progression, transient swelling rates, and changes in tumor morphology were evaluated. Results: Local tumor control and transient swelling rates were 87% and 46%, respectively. Cystic tumors responded better than solid tumors to treatment as evidenced by volume reduction rates 87% vs. 58% , although local control rates were not significantly different 93% vs. 83% . Transient swelling rates were significantly higher in cystic tumors than in solid tumors 67% vs. 29% . Post-treatment volume changes were not correlated with gender, age group, or pre-procedural tumor volume. Conclusion: CyberKnife radiotherapy is an effective way of achieving local tumor control in patients with vestibular schwannomas. Although higher rates of volumetric regression would be expected in more cystic tumors than more solid tumors, local control rates are similar.

Keywords

CyberKnife, hypofractionated stereotactic radiotherapy, vestibular schwannoma

References

• Murphy ES, Suh JH. Radiotherapy for vestibular schwannomas: a critical review. Radiotherapy for vestibular schwannomas: a critical review. Int J Radiat Oncol Biol Phys 2011;79:985-97.
• Bakkouri WE, Kania RE, Guichard JP, Lot G, Herman P, Huy PT. Conservative management of 386 cases of unilateral vestibular schwannoma: tumor growth and consequences for treatment. J Neurosurg 2009;110:662-9.
• Maniakas A, Saliba I. Conservative management versus stereotactic radiation for vestibular schwannomas: a meta-analysis of patients with more than 5 years' follow-up. Otol Neurotol 2012;33:230-8.
• Chan AW, Black P, Ojemann RG, Barker FG, Kooy HM, Lopes VV, et al. Stereotactic radiotherapy for vestibular schwannomas: favorable outcome with minimal toxicity. Neurosurgery 2005;57:60-70.
• Fuss M, Debus J, Lohr F, Huber P, Rhein B, Engenhart- Cabillic R, et al. Conventionally fractionated stereotactic radiotherapy (FSRT) for acoustic neuromas. Int J Radiat Oncol Biol Phys 2000;48:1381-7.
• Combs SE, Volk S, Schulz-Ertner D, Huber PE, Thilmann C, Debus J. Management of acoustic neuromas with fractionated stereotactic radiotherapy (FSRT): long-term results in 106 patients treated in a single institution. Int J Radiat Oncol Biol Phys 2005;63:75-81.
• Vokurka EA, Herwadkar A, Thacker NA, Ramsden RT, Jackson A. Using Bayesian tissue classification to improve the accuracy of vestibular schwannoma volume and growth measurement. AJNR Am J Neuroradiol 2002;23:459-67.
• Varughese JK, Wentzel-Larsen T, Vassbotn F, Moen G, Lund-Johansen M. Analysis of vestibular schwannoma size in multiple dimensions: a comparative cohort study of different measurement techniques. Clin Otolaryngol 2010;35:97-103.
• van de Langenberg R, de Bondt BJ, Nelemans PJ, Baumert BG, Stokroos RJ. Follow-up assessment of vestibular schwannomas: volume quantification versus two-dimensional measurements. Neuroradiology 2009;51:517-24.
• Okunaga T, Matsuo T, Hayashi N, Hayashi Y, Shabani HK, Kaminogo M, et al. Linear accelerator radiosurgery for vestibular schwannoma: measuring tumor volume changes on serial three-dimensional spoiled gradient-echo magnetic resonance images. J Neurosurg 2005;103:53-8.
• Meijer OW, Weijmans EJ, Knol DL, Slotman BJ, Barkhof F, Vandertop WP, et al. Tumor-volume changes after radiosurgery for vestibular schwannoma: implications for follow-up MR imaging protocol. AJNR Am J Neuroradiol 2008;29:906-10.
• Kapoor S, Batra S, Carson K, Shuck J, Kharkar S, Gandhi R, et al. Long-term outcomes of vestibular schwannomas treated with fractionated stereotactic radiotherapy: an institutional experience. Int J Radiat Oncol Biol Phys 2011;81:647-53.
• Lederman G, Lowry J, Wertheim S, Fine M, Lombardi E, Wronski M, et al. Acoustic neuroma: potential benefits of fractionated stereotactic radiosurgery. Stereotact Funct Neurosurg 1997;69:175-82.
• Luetje CM. Spontaneous involution of acoustic tumors. Am J Otol 2000;21:393-8.
• Yu CP, Cheung JY, Leung S, Ho R. Sequential volume mapping for confirmation of negative growth in vestibular schwannomas treated by gamma knife radiosurgery. J Neurosurg 2000;93 Suppl 3:82-9.
• Prasad D, Steiner M, Steiner L. Gamma surgery for vestibular schwannoma. J Neurosurg 2000;92:745- 59.
• Kranzinger M, Zehentmayr F, Fastner G, Oberascher G, Merz F, Nairz O, et al. Hypofractionated stereotactic radiotherapy of acoustic neuroma: volume changes and hearing results after 89-month median follow-up. Strahlenther Onkol 2014;190:798-805.
• Mohammed F, Schwartz M, Lightstone A. Pseudoprogression of vestibular schwannomas after fractionated stereotactic radiation therapy. J Radiat Oncol 2013;2:15-20.
• Nakamura H, Jokura H, Takahashi K, Boku N, Akabane A, Yoshimoto T. Serial follow-up MR imaging after gamma knife radiosurgery for vestibular schwannoma. AJNR Am J Neuroradiol 2000;21:1540-6.